麻豆传媒

Neurology >

Strokes

News, opinions and meeting coverage in neurology.

RSNA: Portable CT Scan Saves Time to Save Brain in Stroke Patients

CHICAGO -- Bringing the CT to the stroke patient, rather than the other way round, dramatically reduced door-to-scan time in a community hospital, researchers said here.

Methamphetamine May Trigger Ischemic Stroke

IRVINE, Calif. -- Methamphetamine users may develop carotid artery dissections, leading to a severe stroke, an effect also seen in cocaine users, according to researchers here.

High Blood Pressure Lowers Walking Ability in Elderly

CHICAGO -- High blood pressure appears to impair older patients' ability to walk, and the reason may be more than just peripheral arterial disease.

High-Dose Steroids Linked to Risk of Atrial Fibrillation

ROTTERDAM, The Netherlands 芒鈧€� High dose corticosteroid therapy may increase the risk of atrial fibrillation, researchers here reported.

Blood Clots Linked to Alzheimer's and Vascular Dementias

MANCHESTER, England 芒鈧€� Spontaneous cerebral blood clots were detected at similar rates in patients with Alzheimer's disease and vascular dementia, suggesting a common pathology and a potentially preventable or treatable cause for some dementias, researchers here said.

ACP: Garlic, Ginseng, Ginkgo Biloba, and Ginger All Bad Actors with Coumadin

PHILADELPHIA - When it comes to adverse events associated with Coumadin (warfarin) therapy, beware of herbs and many supplements beginning with the letter G, according to a University of Washington investigator.

Medicare Will Pay for tPA in Stroke Thrombolysis

WASHINGTON-Medicare is about to announce that beginning in October it will start paying hospitals for use of the thrombolytic drug tissue plasminogen activator (tPA) for treatment of ischemic stroke, according to published reports.

ACC: LDL Cholesterol of Less than 80 mg/dL Reduces Risk of Heart Attack and Stroke

ORLANDO-Cardiologists report that aggressive cholesterol-lowering to new super low target levels of LDL is associated with a 22% reduction in risk of heart attack, stroke, cardiac arrest and death from heart disease for patients with stable coronary disease. The reduction to a mean of 77 mg/dL compared with standard cholesterol-lowering therapy that aims to reduce LDL to about 100 mg/dL. In addition, stroke risk was reduced by 25% compared with risk in patients treated to the recommended target of 100 mg/dL.